Abstract
Attaining desired blood drug concentration and, consequently, augmenting the bioavailability of poorly absorbed drugs have always been an essential aspect for the pharmaceutical agency. The achievement of this target gives positive economic benefits as reducing drug dosage and medical impacts in decreasing toxicity and bacterial resistance in case of antimicrobials. Various factors may reduce the availability of drugs. There are numerous ways to estimate bioavailability. Various software’s models have been developed to simplify such analyses. The newly developed programs should provide a range of modules for pharmacokinetic and pharmacodynamic analysis with a more user-friendly interface.
This is a preview of subscription content, log in via an institution.
References and Further Reading
Abdallah HY, Ludden TM (1995) A spreadsheet program for simulation of bioequivalence and bioavailability studies. Comput Biol Med 25:349–354. https://doi.org/10.1016/0010-4825(95)00015-V
Abo-El-Sooud K, Swielim GA, Wally YR, El-Gammal SM (2016) Comparative biliary and serum kinetics of doxycycline after oral and intramuscular routes with special reference to its unique entero-hepatic circulation in turkeys. Wulfenia 23:206–219
Abo-EL-Sooud K, Mouneir SM, Fahmy MAF (2017) Curcumin ameliorates the absolute and relative bioavailabilities of marbofloxacin after oral administrations in broiler chickens. Wulfenia 24:284–297
Baggot JD, McKellar QA (1994) The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. J Vet Pharmacol Ther 17:409–419
Brown AM (2006) A non-linear regression analysis program for describing electrophysiological data with multiple functions using Microsoft Excel. Comput Methods Prog Biomed 82:51–57. https://doi.org/10.1016/j.cmpb.2006.01.007
Chaudhary A, Nagaich U, Gulati N et al (2012) Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: a recent review. J Adv Pharm Educ Res 2:32–67. https://doi.org/10.1016/S0040-6031(02)00451-3
Chow S-C, Liu J-P (2009) Design and analysis of bioavailability and bioequivalence studies. J Chem Inf Model 53:758. https://doi.org/10.1002/1521-3773(20010316)40:6<9823::AID-ANIE9823>3.3.CO;2-C
Chow S-C, Endrenyi L, Chi E, et al (2011) Bioequivalence & statistical issues in bioavailability/bioequivalence studies. J Bioequiv Availab S1. https://doi.org/10.4172/jbb.S1-007
Cuiné JF, Mcevoy CL, Charman WN et al (2008) Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J Pharm Sci 97:995–1012. https://doi.org/10.1002/jps.21246
Dansirikul C, Choi M, Duffull SB (2005) Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel? Comput Biol Med 35:389–403. https://doi.org/10.1016/j.compbiomed.2004.02.008
De Beule K, Van Gestel J (2001) Pharmacology of itraconazole. Drugs 61:27–37. https://doi.org/10.1016/S1043-6618(02)00088-9
Endrenyi L, Yan W (1993) Variation of Cmax and Cmax/AUC in investigations of bioequivalence. Int J Clin Pharmacol Ther Toxicol 31:184–189
Felmlee MA, Morris ME, Mager DE (2012) Mechanism-based pharmacodynamic modeling. Methods Mol Biol 929:583–600. https://doi.org/10.1007/978-1-62703-050-2-21
Foster DM (2007) Noncompartmental versus compartmental approaches to pharmacokinetic analysis. Princ Clin Pharmacol 8:102–130. https://doi.org/10.1016/B978-0-12-369417-1.50048-1
Gabrielsson JL, Weiner DL (1999) Methodology for pharmacokinetic/pharmacodynamic data analysis. Pharm Sci Technol Today 2:244–252
Gray M, Jones DP (2004) The effect of different formulations of equivalent active ingredients on the performance of two topical wound treatment products. Ostomy Wound Manag 50:34–40
Guerville M, Boudry G (2016) Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation. Am J Physiol – Gastrointest Liver Physiol 311:G1–G15. https://doi.org/10.1152/ajpgi.00098.2016
Hasbach AE, Langlois DK, Rosser EJ, Papich MG (2017) Pharmacokinetics and relative bioavailability of orally administered innovator-formulated itraconazole capsules and solution in healthy dogs. J Vet Intern Med 31:1163–1169. https://doi.org/10.1111/jvim.14779
Howgate EM, Rowland Yeo K, Proctor NJ et al (2006) Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability. Xenobiotica 36:473–497. https://doi.org/10.1080/00498250600683197
Jaki T, Wolfsegger MJ (2012) Non-compartmental estimation of pharmacokinetic parameters for flexible sampling designs. Stat Med 31:1059–1073. https://doi.org/10.1002/sim.4386
Khan AA, Mudassir J, Mohtar N, Darwis Y (2013) Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomedicine 8:2733–2744
Kota J, Machavaram KK, McLennan DN et al (2007) Lymphatic absorption of subcutaneously administered proteins: influence of different injection sites on the absorption of darbepoetin alfa using a sheep model. Drug Metab Dispos 35:2211–2217. https://doi.org/10.1124/dmd.107.015669
Meineke I (2000) An add-in implementation of the RESAMPLING syntax under Microsoft EXCEL. Comput Methods Prog Biomed 63:99–104. https://doi.org/10.1016/S0169-2607(00)00077-8
Morris CA, Duparc S, Borghini-Fuhrer I et al (2011) Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malar J 10:263
Musther H, Olivares-Morales A, Hatley OJD et al (2014) Animal versus human oral drug bioavailability: do they correlate? Eur J Pharm Sci 57:280–291. https://doi.org/10.1016/j.ejps.2013.08.018
Narang N, Sharma J (2011) Sublingual mucosa as a route for systemic drug delivery. Int J Pharm Pharm Sci 3:18–22
Okusanya O, Forrest A, DiFrancesco R et al (2007) Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrob Agents Chemother 51:1822–1826. https://doi.org/10.1128/AAC.00570-06
Persky AM (2012) The impact of team-based learning on a foundational pharmacokinetics course. Am J Pharm Educ 76:1–10. https://doi.org/10.5688/ajpe76231
Plusquellec Y, Efthymiopoulos C, Duthil P, Houin G (1999) A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption. Med Eng Phys 21:525–532
Roberts MS, Magnusson BM, Burczynski FJ, Weiss M (2002) Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 41:751–790. https://doi.org/10.2165/00003088-200241100-00005
Shargel L, Wu-Pong S, Yu A (2016) Applied biopharmaceutics and pharmacokinetics, 7th edn. McGraw-Hill education, New York, USA
Sim DSM (2015) Drug absorption and bioavailability. In: Chan YK, Ng KP, Sim DSM (Eds) Pharmacological basis of acute care. Springer International Publishing, Switzerland, pp 17–26
Tatiraju DV, Bagade VB, Karambelkar PJ et al (2013) Natural bioenhancers: an overview. J Pharmacogn Phytochem 2:55–60
Toutain PL, Bousquet-Mélou A (2004) Bioavailability and its assessment. J Vet Pharmacol Ther 27(6):455–466
Watabe H, Ikoma Y, Kimura Y et al (2006) PET kinetic analysis – compartmental model. Ann Nucl Med 20:583–588. https://doi.org/10.1007/BF02984655
Wolfsegger MJ, Jaki T (2009) Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs. J Pharmacokinet Pharmacodyn 36:479–494. https://doi.org/10.1007/s10928-009-9133-9
Zhang Y, Huo M, Zhou J, Xie S (2010) PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Prog Biomed 99:306–314. https://doi.org/10.1016/j.cmpb.2010.01.007
Zweig AS, Tress ML, Vanden Hoek TL (2007) Absorption of drugs transport of a drug from the GI tract factors affecting drug absorption related to patient. J Pharm Pharmacol 7:23–25
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Abo-EL-Sooud, K. (2018). Absolute and Relative Bioavailability. In: Hock, F., Gralinski, M. (eds) Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-56637-5_16-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56637-5_16-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56637-5
Online ISBN: 978-3-319-56637-5
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences
Publish with us
Chapter history
-
Latest
Absolute and Relative Bioavailability- Published:
- 03 May 2018
DOI: https://doi.org/10.1007/978-3-319-56637-5_16-2
-
Original
Absolute and Relative Bioavailability- Published:
- 06 March 2018
DOI: https://doi.org/10.1007/978-3-319-56637-5_16-1